Latest Breaking News On - Rare enterprises backed concord biotech ltd - Page 1 : comparemela.com

Concord manufactures over 30 products across therapy segments such as immunosuppressant, oncology, antifungal, and antibacterial. Shares of Concord Biotech Ltd ended at ₹1,438, down by ₹4.80, or 0.33%, on the BSE.

Republic of kenyaShoma bhattacharjeeMinistry of health pharmacyConcord biotech ltdRare concord biotech ltd on thursdayRare enterprises backed concord biotech ltdHealth pharmacyPoisons boardConcord biotechReport seriesRare enterprisesInistry of health pharmacy and poisons boardRepublic of kenyaNit ii formulation facilityGood manufacturing practicesOncord biotech bse share price today